Hamlet BioPharma AB publ (XSAT:HAMLET B) ROCE % : -68.63% (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hamlet BioPharma AB publ's annualized ROCE % for the quarter that ended in Sep. 2024 was -68.63%.

Hamlet BioPharma AB publ ROCE % Historical Data

The historical data trend for Hamlet BioPharma AB publ's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ ROCE % Chart

Hamlet BioPharma AB publ Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROCE %

Get a 7-Day Free Trial

-253.07

-113.40

-83.99

-64.23

-94.10

Hamlet BioPharma AB publ Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-82.16	-68.07	-78.69	-67.22	-68.63

Hamlet BioPharma AB publ ROCE % Calculation

Hamlet BioPharma AB publ's annualized ROCE % for the fiscal year that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	-42.534	/	( ( (28.49 - 2.549)	+	(68.566 - 4.108) )	/ 2 )
	=	-42.534	/	( (25.941	+	64.458)	/ 2 )
	=	-42.534	/	45.1995
	=	-94.10 %

Hamlet BioPharma AB publ's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-41.74	/	( ( (68.566 - 4.108)	+	(62.302 - 5.116) )	/ 2 )
	=	-41.74	/	( ( 64.458	+	57.186 )	/ 2 )
	=	-41.74	/	60.822
	=	-68.63 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Hamlet BioPharma AB publ (XSAT:HAMLET B) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hamlet BioPharma AB publ ROCE % Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamlet BioPharma AB publ Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

7ZT:Germany

Address

Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42

Website

http://www.hamletpharma.com

Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines